Literature DB >> 14747438

Computer based receptogram approach: an objective way of assessing immunohistochemistry of androgen receptor staining and its correlation with hormonal response in metastatic carcinoma of prostate.

G Nabi1, A Seth, A K Dinda, N P Gupta.   

Abstract

AIMS: To categorise the immunostaining heterogeneity of androgen receptors in metastatic carcinoma of the prostate using a pattern oriented approach and to correlate the results with response to hormonal treatment.
METHODS: Paraffin wax embedded tumour sections from 85 patients with metastatic carcinoma of the prostate were processed for immunocytochemistry and stained for the androgen receptor using antiandrogen receptor antibodies. A computer based image analysis system was used to analyse the pattern of nuclear immunostaining in a minimum of 500 nuclei/slide. Depending on the nuclear receptor content and concentration, receptogram patterns were established for each specimen. The receptogram pattern was correlated with clinical response to hormonal treatment.
RESULTS: Clinical response to hormonal treatment was documented using prostate specific antigen as the marker into responders (good, fair, stable) and non-responders. Forty four of 48 patients who responded to hormonal treatment had type 1 (35) or type 3 (nine) receptograms, which are characterised by a unimodal peak or multimodal peaks within a narrow concentration range. Thirteen of the 18 patients who stabilised had type 1 or type 3 receptograms. Seventeen of the 19 patients who did not respond to hormonal treatment had either type 2 or type 4 receptograms, which are characterised by skewed or bimodal androgen receptor distribution. Positive and negative predictive values of receptograms were 96.5% and 63%, respectively.
CONCLUSIONS: Image analysis of androgen receptor immunostaining with a receptogram oriented approach provides important prognostic information that can be used to predict response to hormone treatment in patients with metastatic carcinoma of the prostate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747438      PMCID: PMC1770221          DOI: 10.1136/jcp.2003.010520

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Comparison of microscopic imaging strategies for evaluating immunocytochemical (PAP) steroid receptor heterogeneity.

Authors:  R J Sklarew; S C Bodmer; L P Pertschuk
Journal:  Cytometry       Date:  1991

2.  Quantitation of the immunocytochemical assay for estrogen receptor protein (ER-ICA) in human breast cancer by television imaging.

Authors:  R J Sklarew; L P Pertschuk
Journal:  J Histochem Cytochem       Date:  1987-11       Impact factor: 2.479

3.  Heat shock protein (HSP) expression and proliferation of tubular cells in end stage renal disease with and without haemodialysis.

Authors:  A K Dinda; M Mathur; S Guleria; S Saxena; S C Tiwari; S C Dash
Journal:  Nephrol Dial Transplant       Date:  1998-01       Impact factor: 5.992

Review 4.  A critical evaluation of the use of androgen receptor assays to predict the androgen responsiveness of prostatic cancer.

Authors:  E R Barrack; D J Tindall
Journal:  Prog Clin Biol Res       Date:  1987

5.  Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy.

Authors:  M V Sadi; P C Walsh; E R Barrack
Journal:  Cancer       Date:  1991-06-15       Impact factor: 6.860

6.  Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Heterogeneity as a predictor of response to hormonal therapy.

Authors:  M V Sadi; E R Barrack
Journal:  Cancer       Date:  1993-04-15       Impact factor: 6.860

7.  Androgen receptor localization in different cell types of the adult rat prostate.

Authors:  G S Prins; L Birch; G L Greene
Journal:  Endocrinology       Date:  1991-12       Impact factor: 4.736

8.  Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system.

Authors:  J T Isaacs; N Wake; D S Coffey; A A Sandberg
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

9.  Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis.

Authors:  W D Tilley; S S Lim-Tio; D J Horsfall; J O Aspinall; V R Marshall; J M Skinner
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

10.  Immunostaining for prostate cancer androgen receptor in paraffin identifies a subset of men with a poor prognosis.

Authors:  L P Pertschuk; H Schaeffer; J G Feldman; R J Macchia; Y D Kim; K Eisenberg; L V Braithwaite; C A Axiotis; G Prins; G L Green
Journal:  Lab Invest       Date:  1995-08       Impact factor: 5.662

View more
  5 in total

1.  Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: validation of a new computer-assisted image analysis procedure.

Authors:  Marylène Lejeune; Joaquín Jaén; Lluis Pons; Carlos López; Maria-Teresa Salvadó; Ramón Bosch; Marcial García; Patricia Escrivà; Jordi Baucells; Xavier Cugat; Tomás Alvaro
Journal:  J Anat       Date:  2008-06       Impact factor: 2.610

Review 2.  Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer.

Authors:  Petros D Grivas; Diane M Robins; Maha Hussain
Journal:  Crit Rev Oncol Hematol       Date:  2012-06-16       Impact factor: 6.312

3.  Differential expression of RDC1/CXCR7 in the human placenta.

Authors:  Vishwas Tripathi; Romsha Verma; Amit Dinda; Neena Malhotra; Jagdeep Kaur; Kalpana Luthra
Journal:  J Clin Immunol       Date:  2008-10-28       Impact factor: 8.317

Review 4.  A role for the androgen-receptor in clinically localized and advanced prostate cancer.

Authors:  James L Mohler
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2008-04       Impact factor: 4.690

5.  Java Web Start based software for automated quantitative nuclear analysis of prostate cancer and benign prostate hyperplasia.

Authors:  Swaroop S Singh; Desok Kim; James L Mohler
Journal:  Biomed Eng Online       Date:  2005-05-11       Impact factor: 2.819

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.